BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23503166)

  • 1. Amino acid substitutions in GyrA and ParC are associated with fluoroquinolone resistance in Mycoplasma bovis isolates from Japanese dairy calves.
    Sato T; Okubo T; Usui M; Higuchi H; Tamura Y
    J Vet Med Sci; 2013; 75(8):1063-5. PubMed ID: 23503166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Korzheva N; Davies TA; Goldschmidt R
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance.
    Hirose K; Kawasaki Y; Kotani K; Abiko K; Sato H
    J Vet Med B Infect Dis Vet Public Health; 2004 May; 51(4):169-75. PubMed ID: 15228551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
    Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
    BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the Quinolone Resistance-Determining Regions and Fluoroquinolone Resistance in Clinical Isolates and Laboratory-Derived Mutants of Mycoplasma bovis: Not All Genotypes May Be Equal.
    Khalil D; Becker CAM; Tardy F
    Appl Environ Microbiol; 2016 Feb; 82(4):1060-1068. PubMed ID: 26637606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
    Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
    J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in GyrA and ParC in fluoroquinolone-resistant Mannheimia haemolytica isolates from cattle in Japan.
    Ozawa M; Asai T; Sameshima T
    J Vet Med Sci; 2009 Apr; 71(4):493-4. PubMed ID: 19420855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis.
    Lysnyansky I; Mikula I; Gerchman I; Levisohn S
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4911-4. PubMed ID: 19721062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutations of gyrA gene and parC gene in fluoroquinolone-resistant Escherichia coli isolates from sporadic diarrheal cases].
    Ishiguro F; Toho M; Yamazaki M; Matsuyuki S; Moriya K; Tanaka D; Isobe J; Kyota Y; Muraoka M
    Kansenshogaku Zasshi; 2006 Sep; 80(5):507-12. PubMed ID: 17073264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
    Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
    Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
    Urushibara N; Suzaki K; Kawaguchiya M; Aung MS; Shinagawa M; Takahashi S; Kobayashi N
    Microb Drug Resist; 2018; 24(1):1-7. PubMed ID: 28504916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone resistance and molecular characterization of gyrA and parC quinolone resistance-determining regions in Escherichia coli isolated from poultry.
    Vanni M; Meucci V; Tognetti R; Cagnardi P; Montesissa C; Piccirillo A; Rossi AM; Di Bello D; Intorre L
    Poult Sci; 2014 Apr; 93(4):856-63. PubMed ID: 24706962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of fluoroquinolone resistance in Escherichia coli strains from ruminants.
    Jurado S; Orden JA; Horcajo P; De La Fuente R; Ruiz-Santa-Quiteria JA; Martínez-Pulgarín S; Domínguez-Bernal G
    J Vet Diagn Invest; 2008 May; 20(3):342-5. PubMed ID: 18460623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of fluoroquinolone resistance mechanism in Mycoplasma hominis isolated from urogenital samples in a Chinese hospital.
    Zhang H; Zheng L; Zhao J; Ding S; Xia Y
    J Med Microbiol; 2019 Feb; 68(2):206-210. PubMed ID: 30632961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
    Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
    Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH; Kuo SC; Lee YT; Chang IC; Yang SP; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a novel single-nucleotide-polymorphism real-time PCR assay for rapid detection of fluoroquinolone-resistant Mycoplasma bovis.
    Ben Shabat M; Mikula I; Gerchman I; Lysnyansky I
    J Clin Microbiol; 2010 Aug; 48(8):2909-15. PubMed ID: 20534803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
    Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.